stockrowNovoCure Limited (NVCR) vs Tandem Diabetes Care, Inc. (TNDM)
- NovoCure Limited NVCR 13.26 −2.14%
- Tandem Diabetes Care, Inc. TNDM 16.78 −6.73%
NovoCure Limited and Tandem Diabetes Care, Inc. are both Medical Devices companies. NovoCure Limited is the larger, with a market value of $1.6B against $1.3B — 1.3× the size. NovoCure Limited grew revenue faster over the last twelve months: 12.9% against 6.84%. Tandem Diabetes Care, Inc. has the higher net margin (−4.58% vs −16.8%) and the higher return on invested capital (−5.35% vs −106.1%). Across the 18 metrics below, Tandem Diabetes Care, Inc. leads on 11 and NovoCure Limited on 7.
Valuation
Profitability
| Metric | NVCR | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.02% | 56.65% | 57.76% |
| Operating margin | (17.17%) | (2.35%) | (15.07%) |
| Net margin | (16.78%) | (4.58%) | (14.45%) |
| Free cash flow margin | (3.39%) | (3.37%) | (3.88%) |
| Return on equity | (35.18%) | (36.74%) | (10.35%) |
| Return on assets | (11.12%) | (4.84%) | (17.26%) |
| Return on invested capital | (106.10%) | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack